DrugPatentWatch Database Preview

Eli Lilly And Co Company Profile

ELI LILLY AND CO has seven approved drugs.

There are thirteen US patents protecting ELI LILLY AND CO drugs.

There are one hundred and eighty-three patent family members on ELI LILLY AND CO drugs in fifty countries and eighty-four supplementary protection certificates in fifteen countries.

International Patents:	183
US Patents:	13
Tradenames:	8
Ingredients:	7
NDAs:	7
Drug Master File Entries:	37
Patent Litigation for Eli Lilly And Co:	See patent lawsuits for Eli Lilly And Co
PTAB Cases with Eli Lilly And Co as patent owner:	See PTAB cases with Eli Lilly And Co as patent owner

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eli Lilly And Co	AXIRON	testosterone	SOLUTION, METERED;TRANSDERMAL	022504-001	Nov 23, 2010		DISCN	Yes	No	8,435,944	➤ Sign Up				➤ Sign Up
Eli Lilly And Co	AXIRON	testosterone	SOLUTION, METERED;TRANSDERMAL	022504-001	Nov 23, 2010		DISCN	Yes	No	8,419,307	➤ Sign Up				➤ Sign Up
Eli Lilly And Co	SARAFEM	fluoxetine hydrochloride	CAPSULE;ORAL	018936-007	Jul 6, 2000		DISCN	Yes	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Eli Lilly And Co	HUMALOG KWIKPEN	insulin lispro recombinant	SOLUTION;SUBCUTANEOUS	205747-001	May 26, 2015	6,034,054	➤ Sign Up
Eli Lilly And Co	SARAFEM	fluoxetine hydrochloride	CAPSULE;ORAL	018936-007	Jul 6, 2000	4,971,998*PED	➤ Sign Up
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-001	Dec 29, 1987	4,035,511	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Solution	30 mg/1.5 mL	➤ Subscribe	2013-01-29
➤ Subscribe	Tablets	5 mg and 10 mg	➤ Subscribe	2013-07-10

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Japan	2010515490	➤ Sign Up
Hong Kong	1136228	➤ Sign Up
World Intellectual Property Organization (WIPO)	2010075074	➤ Sign Up
Country	Patent Number	Estimated Expiration

Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2498802	CR 2017 00020	Denmark	➤ Sign Up	PRODUCT NAME: INSULIN GLARGINE/LIXISENATID; REG. NO/DATE: EU/1/16/1157/001-004 20170113
0792290	SPC/GB04/036	United Kingdom	➤ Sign Up	PRODUCT NAME: INSULIN DETEMIR, NEB29- TETRADECANOYL- DES(B30) HUMAN INSULIN; NATL REGISTRATION NO/DATE: EU/1/04/278/001-009 20040601; FIRST REGISTRATION: CH 56370, 56311, 56372 20031110
0885961	05C0009	France	➤ Sign Up	PRODUCT NAME: INSULINE GLULISINE; REGISTRATION NO/DATE IN FRANCE: EU/1/04/258/001 DU 20040927; REGISTRATION NO/DATE AT EEC: EU/1/04/285/001 DU 20040927
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.